Imunon (IMNN) EBITDA Margin (2017 - 2022)
Imunon's EBITDA Margin came in at -5524.24% for Q4 2022, down 1259.69 percentage points from -4264.55% a year earlier and down 721.87 percentage points from the prior quarter.
Powered by 
Analysis
Imunon (IMNN) EBITDA Margin (2017 - 2022) Analysis & Trends
For FY2022, Imunon's EBITDA Margin was -4877.31%, down 816.46 percentage points from FY2021.
- EBITDA Margin carries a five-year change of -1349.69 percentage points (FY2017 to FY2022).
- Going back by year, EBITDA Margin was -4060.85% in FY2021 (-511.88 pp), -3548.98% in FY2020 (+419.78 pp), -3968.76% in FY2019 (+172.88 pp) and -4141.64% in FY2018 (-614.02 pp).
- The Q4 2022 figure represents the lowest quarterly EBITDA Margin since Q2 2018.
- Year-over-year, EBITDA Margin has declined for nine consecutive quarters, with an average year-over-year change of -664.17 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2019 (a gain of 2022.12 percentage points), and the weakest in Q2 2018 (a drop of 2957.29 percentage points).
- Business Quant data shows IMNN's EBITDA Margin at -4802.37% (Q3 2022), -4648.24% (Q2 2022) and -4534.39% (Q1 2022) in the three quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Imunon | 6.10 Mn | 6.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -5,487.69% |
| Sep 30, 2022 | -4,766.42% |
| Jun 30, 2022 | -4,611.99% |
| Mar 31, 2022 | -4,498.14% |
| Dec 31, 2021 | -4,228.00% |
| Sep 30, 2021 | -3,885.56% |
| Jun 30, 2021 | -3,815.69% |
| Mar 31, 2021 | -4,124.36% |
| Dec 31, 2020 | -3,693.36% |
| Sep 30, 2020 | -2,975.63% |
| Jun 30, 2020 | -3,583.69% |
| Mar 31, 2020 | -3,585.25% |
| Dec 31, 2019 | -3,572.60% |
| Sep 30, 2019 | -4,091.91% |
| Jun 30, 2019 | -4,241.82% |
| Mar 31, 2019 | -3,659.41% |
| Dec 31, 2018 | -3,646.05% |
| Sep 30, 2018 | -3,070.07% |
| Jun 30, 2018 | -6,339.35% |
| Mar 31, 2018 | -3,355.15% |
API Access
Imunon EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IMNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();